Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Tamsulosin and finasteride together effectively slow down and prevent BPH progression.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Some people with Frontal Fibrosing Alopecia may be allergic to a common sunscreen ingredient.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Fzd2 is important for skin and hair development through various signaling ways.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Trastuzumab may cause tufted hair folliculitis as a side effect.

New hybrid compound found to effectively prevent hair loss.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

BTA safely and effectively treats hair loss, and works better with FNS.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

These medications for BPH have known risks and may have new side effects.